Clinical Trial Update: A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers [Phase 4]

View source ↗

Summary

This post-marketing Phase 4 trial of Apligraf for venous leg ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicose Ulcer
• Venous Leg Ulcer

Drugs mentioned

• Apligraf

Snippet

Sponsor: Organogenesis | Conditions: Varicose Ulcer | Phase 4 | Status: WITHDRAWN